Connect with us

Life Sciences

Using Single Cell Spatial Profiling to Study Therapeutic Response in Neurological Disease and Injury

In this GEN webinar, our distinguished speaker Dr. Simon Gregory from the Duke Molecular Physiology Institute will demonstrate how 10x Genomics’ Xenium…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Broadcast Date: November 9, 2023
Time: 9:00 am PT, 12:00 pm ET, 18:00 CET

The human brain has ~170 billion cells, with roughly 170 trillion synaptic connections, organized into distinct regions, structures, and cortical layers. This complex intersection between cellular connectivity and neuroanatomy has made it challenging to untangle discrete functions in health and disease. Spatial profiling at the single cell level makes it possible to move beyond deductive science and delve into the gene expression changes occurring in tissue micro environments during disease development and therapeutic response more directly.  

In this GEN webinar, our distinguished speaker Dr. Simon Gregory will demonstrate how 10x Genomics’ Xenium Mouse Brain Gene Expression Panel and a Custom Add-on Panel can be used to characterize therapeutic response in brain cancer and white matter injury repair. He will demonstrate the use of single cell spatial imaging with these panels to examine pathological processes associated with the development of diffuse midline glioma, and tumor response to a novel therapeutic intervention. He will also share results assessing the impact of a new oxysterol therapy on an intestinal perforation model of cerebral palsy. 

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

Simon Gregory
Simon Gregory, PhD
Vice Chair for Research in the Department of Neurology Professor in Molecular Genetics and Microbiology Professor in Neurology Duke Molecular Physiology Institute
Duke Molecular Physiology Institute

 

The post Using Single Cell Spatial Profiling to Study Therapeutic Response in Neurological Disease and Injury appeared first on GEN – Genetic Engineering and Biotechnology News.

Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Markets

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending